Inovio Pharmaceuticals Inc
NASDAQ:INO
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3.97
13.88
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Inovio Pharmaceuticals Inc
Wall Street
Price Targets
INO Price Targets Summary
Inovio Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
INO
is 10.88 USD
with a low forecast of 5.05 USD and a high forecast of 18.9 USD.
INO Last Price Targets
Inovio Pharmaceuticals Inc
The latest public price target was made on Aug 9, 2024 by
Gregory Renza
from
RBC Capital
,
who expects
INO
stock to
rise by 92%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Gregory Renza
RBC Capital
|
8
USD
Upside 92% |
3 months ago
Aug 9, 2024
|
Inovio Pharmaceuticals (INO) PT Lowered to $8 at RBC Capital
StreetInsider
|
Hartaj Singh
Oppenheimer
|
40
USD
Upside 858% |
6 months ago
May 14, 2024
|
Oppenheimer Reiterates Outperform Rating on Inovio Pharmaceuticals (INO)
StreetInsider
|
|
Sudan Loganathan
Stephens
|
20
USD
Upside 379% |
6 months ago
May 13, 2024
|
Inovio initiated with an Overweight at Stephens
TheFly
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is INO's stock price target?
Price Target
10.88
USD
According to Wall Street analysts, the average 1-year price target for
INO
is 10.88 USD
with a low forecast of 5.05 USD and a high forecast of 18.9 USD.
What is Inovio Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
172%
For the last 8 years the
compound annual growth rate for
Inovio Pharmaceuticals Inc's revenue is
-38%.
The projected
CAGR
for the next 3 years is
172%.
You don't have any saved screeners yet
